Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record36012 flagged findings
Reported transactions (Form 4)80since May 24, 2023 · and 5 other holdings
Corporate events (8-K)24since Nov 4, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-04-21share offering or dilution eventrecentOpen filing ↗“…holder shall remain subject to the same restrictions. The restrictions on transfers or other dispositions by us described above do…”
+1 more passage from the same document
- “…dispositions by us described above do not apply to: (a) the securities to be sold in this offering, including the issuance by us of…”
- 2026-04-21capital return (buybacks/dividends)recentOpen filing ↗“…made during the restricted period and (C) to the extent a filing under Section 16(a) of the Exchange Act is required during the…”
+1 more passage from the same document
- “…the method used to determine such rate or rates; • the date or dates from which interest, if any, will be payable and any…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 360)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 10, 268-K ↗Current report · Communication to the market
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Results
- Jul 8, 26SCHEDULE 13G ↗Passive stake · Soleus Capital Management, L.P. · 5.2% · event on Apr 21, 26
- Jun 10, 268-K ↗Current report · Shareholder vote results
- May 12, 2610-Q ↗Quarterly report
- May 12, 268-K ↗Current report · Results · Communication to the market
- May 4, 26Form 4 ↗Insider transaction
- Apr 29, 26DEFA14A ↗Shareholder meeting and votes
- Apr 29, 26DEF 14A ↗Shareholder meeting and votes
- Apr 28, 26SCHEDULE 13G ↗Passive stake · RA Capital Management, L.P. · 9.9% · event on Apr 21, 26
- Apr 28, 26Form 4 ↗Insider transaction
- Apr 28, 26Form 3 ↗Insider transaction
- Apr 23, 26SCHEDULE 13D/A ↗Stake with intent to influence · ORBIMED ADVISORS LLC · 16.0% · event on Apr 21, 26 · amendment
- Apr 22, 26SCHEDULE 13D/A ↗Stake with intent to influence · Baker Bros. Advisors LP · 15.5% · event on Apr 20, 26 · amendment
- Apr 21, 268-K ↗Current report · Entered a material agreement
360 filings on record, the oldest from Aug 19, 20.
Listing the 25 most recent filings of the 360 on record.
1914
- Apr 21, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 15, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 4, 25Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Oct 17, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 13, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 28, 25Listing notice (8-K 3.01)8-K 3.01 ↗
3 senior executive changes2024 – 2025show all 3hide
- Feb 5, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 16, 24A senior executive left or was appointed8-K/A 5.02 ↗
- Apr 10, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Dec 11, 23Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- May 19, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Mar 15, 23Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Apr 8, 22A senior executive left or was appointed8-K 5.02 ↗
- Mar 9, 22A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
7 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- ORBIMED ADVISORS LLC16.0%Apr 21, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Baker Bros. Advisors LP15.5%Apr 20, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Vaddi Krishna13.2%Dec 31, 25SCHEDULE 13G/A ↗2 earlier filings
- RA Capital Management, L.P.9.9%Apr 21, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- INCYTE CORP9.9%Nov 3, 25SCHEDULE 13G ↗
- Soleus Capital Management, L.P.5.2%Apr 21, 26SCHEDULE 13G ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Apr 21, 26Buy$5.0MORBIMED ADVISORS LLC↗
- Apr 21, 26Buy$7.5MORBIMED ADVISORS LLC↗
- Mar 25, 25Buy$467KKrishna VaddiCEO↗
- Mar 25, 25Buy$69KAndrew CombsChief Chemistry Officer↗
- Mar 21, 25Buy$11KKrishna VaddiCEO↗
- Mar 20, 25Buy$4KKrishna VaddiCEO↗
- Mar 17, 25Buy$7KKrishna VaddiCEO↗
- Mar 14, 25Buy$23KKrishna VaddiCEO↗
- Mar 13, 25Buy$36KKrishna VaddiCEO↗
- Mar 12, 25Buy$34KKrishna VaddiCEO↗
- Dec 31, 24Buy$6KKrishna VaddiCEO↗
- Dec 30, 24Buy$12KKrishna VaddiCEO↗
There are 8 more transactions in this stretch.
Stock compensation, tax and giftsshow the 20 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Apr 27, 26Otheramount n/aRA CAPITAL MANAGEMENT, L.P.↗
- Oct 4, 25Compensationamount n/aJane HuangPresident, CMO↗
- Oct 4, 25Tax$5KJane HuangPresident, CMO↗
- Jul 4, 25Compensationamount n/aJane HuangPresident, CMO↗
- Jul 4, 25Tax$3KJane HuangPresident, CMO↗
- Apr 4, 25Compensationamount n/aJane HuangPresident, CMO↗
- Apr 4, 25Tax$2KJane HuangPresident, CMO↗
- Jan 4, 25Compensationamount n/aJane HuangPresident, CMO↗
- Jan 4, 25Tax$5KJane HuangPresident, CMO↗
- Oct 4, 24Compensationamount n/aJane HuangPresident, CMO↗
- Oct 4, 24Tax$7KJane HuangPresident, CMO↗
- Jul 4, 24Compensationamount n/aJane HuangPresident, CMO↗
- Jul 4, 24Tax$12KJane HuangPresident, CMO↗
- Apr 4, 24Compensationamount n/aJane HuangPresident, CMO↗
- Apr 4, 24Tax$16KJane HuangPresident, CMO↗
- Jan 4, 24Compensationamount n/aJane HuangPresident, CMO↗
- Jan 4, 24Tax$14KJane HuangPresident, CMO↗
- Oct 4, 23Compensationamount n/aJane HuangPresident, CMO↗
- Jul 4, 23Compensationamount n/aJane HuangPresident, CMO↗
- Jul 4, 23Tax$15KJane HuangPresident, CMO↗
The full record holds 45 transactions and goes back to Feb 7, 23.
Its sector and its market
Prelude Therapeutics Incorporated among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Prelude Therapeutics Incorporated, the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Prelude Therapeutics Incorporated in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 360 documents on file, from Aug 19, 2020 to Sep 10, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.